Primary Site >> Biliary tract Cancer
Gene >> VEGFA
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels. PMID: 1940805 |
Ref: Expression of vascular endothelial growth factor correlates with tumor progression in gallbladder cancer. PMID: 9538121 Ref: Expression of vascular endothelial growth factor in human gallbladder lesions. PMID: 9683809 Ref: Enhanced expression of thrombospondin-1 and hypovascularity in human cholangiocarcinoma. PMID: 9828214 |
Ref: Expression of angiogenic factors, basic fibroblast growth factor and vascular endothelial growth factor, in human biliary tract carcinoma cell lines. PMID: 11282489 Ref: Association of p53, p16, and vascular endothelial growth factor protein expressions with the prognosis and metastasis of gallbladder cancer. PMID: 11584965 |
Ref: Vascular endothelial growth factor-C expression in human gallbladder cancer and its relationship to lymph node metastasis. PMID: 12469214 Ref: Transforming growth factor beta 1 stimulates vascular endothelial growth factor gene transcription in human cholangiocellular carcinoma cells. PMID: 12615726 Ref: Development of a therapeutic adenoviral vector for cholangiocarcinoma combining tumor-restricted gene expression and infectivity enhancement. PMID: 12654561 Ref: [The roles of VEGF and C-myc in occurrence, development and metastasis of gallbladder carcinoma]. PMID: 12744166 |
Ref: Relationship between urokinase-type plasminogen activator receptor and vascular endothelial growth factor expression and metastasis of gallbladder cancer. PMID: 15309734 |
Ref: Cyclooxygenase-2 promotes angiogenesis by increasing vascular endothelial growth factor and predicts prognosis in gallbladder carcinoma. PMID: 15968728 Ref: Vascular endothelial growth factor (VEGF) expression is not associated with prognosis in patients with radically resected ampullary carcinoma. PMID: 15972277 Ref: gamma-Aminobutyric acid inhibits cholangiocarcinoma growth by cyclic AMP-dependent regulation of the protein kinase A/extracellular signal-regulated kinase 1/2 pathway. PMID: 16357152 |
Ref: Angiogenesis in cholangiocellular carcinoma: expression of vascular endothelial growth factor, angiopoietin-1/2, thrombospondin-1 and clinicopathological significance. PMID: 16465407 Ref: COX-2 expression in ampullary carcinoma: correlation with angiogenesis process and clinicopathological variables. PMID: 16489179 Ref: Analysis of p53 and vascular endothelial growth factor expression in human gallbladder carcinoma for the determination of tumor vascularity. PMID: 16489641 Ref: Prognostic significance of vascular endothelial growth factor expression and microvessel density in carcinoma of ampulla of Vater. PMID: 16506374 Ref: [Effects of norcantharidin on angiogenesis of human gallbladder carcinoma and its anti-angiogenic mechanisms]. PMID: 16681930 Ref: Hypoxia inducible factors 1alpha and 2alpha are associated with VEGF expression and angiogenesis in gallbladder carcinomas. PMID: 16900513 |
Ref: Evaluation of VEGF A expression and microvascular density as prognostic factors in extrahepatic cholangiocarcinoma. PMID: 17400419 Ref: Serum and biliary insulin-like growth factor I and vascular endothelial growth factor in determining the cause of obstructive cholestasis. PMID: 17909206 Ref: [Effects of vascular endothelial growth factor (VEGF) antisense oligodeoxynucleotide on mRNA and expression of VEGF, flt-1, and kinase insert domain containing receptor and VEGF excretion in human gallbladder carcinoma cells]. PMID: 18478945 |
Ref: Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma. PMID: 18087285 Ref: Thalidomide attenuates tumor growth and preserves fast-twitch skeletal muscle fibers in cholangiocarcinoma rats. PMID: 18291259 Ref: Variants in inflammation genes and the risk of biliary tract cancers and stones: a population-based study in China. PMID: 18676870 Ref: Role of tumor angiogenesis in gallbladder carcinoma: with special reference to thymidine phosphorylase. PMID: 18946757 |
Ref: Estrogens stimulate the proliferation of human cholangiocarcinoma by inducing the expression and secretion of vascular endothelial growth factor. PMID: 18395502 Ref: Cholangiocarcinoma: estrogen-induced autocrine effects of VEGF on cell proliferation. PMID: 19112054 Ref: Endothelin inhibits cholangiocarcinoma growth by a decrease in the vascular endothelial growth factor expression. PMID: 19291182 Ref: Vandetanib (ZD6474), an inhibitor of VEGFR and EGFR signalling, as a novel molecular-targeted therapy against cholangiocarcinoma. PMID: 19319137 Ref: Comparative protein expression profiles of hilar and peripheral hepatic cholangiocarcinomas. PMID: 19446907 Ref: H3 histamine receptor-mediated activation of protein kinase Calpha inhibits the growth of cholangiocarcinoma in vitro and in vivo. PMID: 19825989 |
Ref: Effect of Helicobacter bilis infection on human bile duct cancer cells. PMID: 19731027 Ref: Expression of hypoxia-inducible factor-1 alpha (HIF-1alpha) in patients with the gallbladder carcinoma. PMID: 20082206 Ref: Molecular targeted therapy of biliary tract cancer--results of the first clinical studies. PMID: 20388063 Ref: Report of a multicenter phase II trial testing a combination of biweekly bevacizumab and daily erlotinib in patients with unresectable biliary cancer: a phase II Consortium study. PMID: 20530271 Ref: Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma. PMID: 20545696 Ref: Circulating CD14(+) CD16(+) monocyte levels predict tissue invasive character of cholangiocarcinoma. PMID: 20636398 Ref: Advances in the treatment of metastatic or unresectable biliary tract cancer. PMID: 20943640 |
Ref: Expression and clinical significance of hepatoma-derived growth factor as a prognostic factor in human hilar cholangiocarcinoma. PMID: 20848225 Ref: The prognostic relevance of tumor hypoxia markers in resected carcinoma of the gallbladder. PMID: 21109386 Ref: Potent in vitro and in vivo antitumor activity of sorafenib against human intrahepatic cholangiocarcinoma cells. PMID: 21331764 Ref: Advantages of laserphyrin compared with photofrin in photodynamic therapy for bile duct carcinoma. PMID: 21360081 Ref: Array comparative genomic hybridization identifies novel potential therapeutic targets in cholangiocarcinoma. PMID: 21492330 Ref: Prognostic impact of vascular endothelial growth factor-A expression in resected gallbladder carcinoma. PMID: 21853312 |
Ref: SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma. PMID: 21748296 Ref: Inhibition of histidine decarboxylase ablates the autocrine tumorigenic effects of histamine in human cholangiocarcinoma. PMID: 21873469 Ref: Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo. PMID: 22200632 Ref: Inflammatory gene variants and the risk of biliary tract cancers and stones: a population-based study in China. PMID: 23057767 |
Ref: Characterization of two novel cell lines with distinct heterogeneity derived from a single human bile duct carcinoma. PMID: 23382894 Ref: Inhibition of SCAMP1 suppresses cell migration and invasion in human pancreatic and gallbladder cancer cells. PMID: 23653380 Ref: EGFR, FLT1 and heparanase as markers identifying patients at risk of short survival in cholangiocarcinoma. PMID: 23704979 Ref: Quantitative analysis of VEGF-C mRNA of extrahepatic cholangiocarcinoma with real-time PCR using samples obtained during endoscopic retrograde cholangiopancreatography. PMID: 23721191 Ref: Vascular endothelial growth factor levels in bile distinguishes pancreatic cancer from other etiologies of biliary stricture: a pilot study. PMID: 23828141 Ref: Vascular endothelial growth factor single-nucleotide polymorphism in gallbladder cancer. PMID: 23962084 Ref: [Asymptomatic longterm survival in a patient with sigmoid colon lymph node metastasis with cancerous ascites of unknown origin]. PMID: 23986064 Ref: Effects of single nucleotide polymorphisms on treatment outcomes and toxicity in patients treated with sunitinib. PMID: 24123039 Ref: Expression of vascular endothelial growth factors and their receptors by hepatic progenitor cells in human liver diseases. PMID: 24570919 |
Ref: Immunohistochemical expression of vascular endothelial growth factor A in advanced gallbladder carcinoma. PMID: 24185122 Ref: Overexpression of membrane metalloendopeptidase inhibits substance P stimulation of cholangiocarcinoma growth. PMID: 24603459 Ref: Thymoquinone induces G2/M arrest, inactivates PI3K/Akt and nuclear factor-kappaB pathways in human cholangiocarcinomas both in vitro and in vivo. PMID: 24603952 Ref: Differences in immunohistochemical biomarkers between intra- and extrahepatic cholangiocarcinoma: a systematic review and meta-analysis. PMID: 24787096 Ref: Inhibition of tumor angiogenesis by interferon-gamma by suppression of tumor-associated macrophage differentiation. PMID: 24854099 Ref: A review of recent data in the treatment of gallbladder cancer: what we know, what we do, and what should be done. PMID: 24857099 Ref: Transcriptional profiles of peripheral blood leukocytes identify patients with cholangiocarcinoma and predict outcome. PMID: 24935374 Ref: miR-1 and miR-145 act as tumor suppressor microRNAs in gallbladder cancer. PMID: 24966896 Ref: Tumor necrosis factor-alpha promotes the lymphangiogenesis of gallbladder carcinoma through nuclear factor-kappaB-mediated upregulation of vascular endothelial growth factor-C. PMID: 25154789 Ref: Expression of epidermal growth factor receptor, p53, Bcl2, vascular endothelial growth factor, cyclooxygenase-2, cyclin D1, human epidermal receptor-2 and Ki-67: Association with clinicopathological profiles and outcomes in gallbladder carcinoma. PMID: 25225463 Ref: FTY720 inhibits proliferation and epithelial-mesenchymal transition in cholangiocarcinoma by inactivating STAT3 signaling. PMID: 25344679 |
Ref: Prognostic implications of estrogen receptor 1 and vascular endothelial growth factor A expression in primary gallbladder carcinoma. PMID: 25632198 Ref: Systemic therapy of cholangiocarcinoma: From chemotherapy to targeted therapies. PMID: 25966433 Ref: Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial. PMID: 26179201 Ref: Cholangiocarcinoma: Correlation between Molecular Profiling and Imaging Phenotypes. PMID: 26207380 Ref: Prognostic molecular markers in resected extrahepatic biliary tract cancers; a systematic review and meta-analysis of immunohistochemically detected biomarkers. PMID: 26223884 Ref: MicroRNA-101 inhibits the migration and invasion of intrahepatic cholangiocarcinoma cells via direct suppression of vascular endothelial growth factor-C. PMID: 26299768 Ref: Ischemia reperfusion of the hepatic artery induces the functional damage of large bile ducts by changes in the expression of angiogenic factors. PMID: 26451003 Ref: Dual role of CD44 isoforms in ampullary adenocarcinoma: CD44s predicts poor prognosis in early cancer and CD44nu is an indicator for recurrence in advanced cancer. PMID: 26572077 Ref: Complete Response to Erlotinib and Bevacizumab in a Patient With Biphenotypic (Hepatobiliary) Primary Liver Carcinoma. PMID: 26656516 |
Ref: Clinicopathological characteristics and liver stem cell marker expression in hepatocellular carcinoma involving bile duct tumor thrombi. PMID: 26586401 Ref: Inhibition of hypoxia inducible factor 1 and topoisomerase with acriflavine sensitizes perihilar cholangiocarcinomas to photodynamic therapy. PMID: 26657503 Ref: Systemic therapy for biliary cancers. PMID: 27829278 |
Ref: DUSP1 inhibits cell proliferation, metastasis and invasion and angiogenesis in gallbladder cancer. PMID: 28129656 Ref: Targeting Angiogenesis in Biliary Tract Cancers: An Open Option. PMID: 28212293 Ref: Efficacy and safety of chemotherapy with or without targeted therapy in biliary tract cancer: A meta-analysis of 7 randomized controlled trials. PMID: 28397047 Ref: Integrated mRNA and lncRNA expression profiling for exploring metastatic biomarkers of human intrahepatic cholangiocarcinoma. PMID: 28401021 Ref: Tropomyosin-related kinase B mediated signaling contributes to the induction of malignant phenotype of gallbladder cancer. PMID: 28423707 |
Ref: Genotyping and mRNA profiling reveal actionable molecular targets in biliary tract cancers. PMID: 29416916 Ref: ISL1 is upregulated in breast cancer and promotes cell proliferation, invasion, and angiogenesis. PMID: 29497310 Ref: PF-2341066 combined with celecoxib promotes apoptosis and inhibits proliferation in human cholangiocarcinoma QBC939 cells. PMID: 29725387 Ref: Circulating biomarkers during treatment in patients with advanced biliary tract cancer receiving cediranib in the UK ABC-03 trial. PMID: 29925934 Ref: Inhibiting the proliferation and metastasis of hilar cholangiocarcinoma cells by blocking the expression of vascular endothelial growth factor with small interfering RNA. PMID: 30008874 Ref: Serum vascular endothelial growth factor-C levels predict lymph node metastasis and prognosis of patients with gallbladder cancer. PMID: 30344750 |